ロード中...
Tumor Necrosis Factor Inhibition in the Acute Management of Traumatic Optic Neuropathy
PURPOSE: To determine the effectiveness of etanercept, a tumor necrosis factor (TNF) inhibitor, in conferring neuroprotection to retinal ganglion cells (RGCs) and improving visual outcomes after optic nerve trauma with either optic nerve crush (ONC) or sonication-induced traumatic optic neuropathy (...
保存先:
| 出版年: | Invest Ophthalmol Vis Sci |
|---|---|
| 主要な著者: | , , , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
The Association for Research in Vision and Ophthalmology
2018
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5989875/ https://ncbi.nlm.nih.gov/pubmed/30025145 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1167/iovs.18-24431 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|